Sphera Funds Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sphera Funds Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-168,000	Closed	-$8.87M	–	135
2018 Q1	$8.87M	Buy	168,000 +10,000	+6%	+$583K	1.35%	19
2017 Q4	$10.7M	Hold	158,000	–	–	1.26%	15
2017 Q3	$13M	Buy	158,000 +65,000	+70%	+$5.15M	1.86%	11
2017 Q2	$8.71M	Buy	+93,000	New	+$5.69M	1.48%	16
2016 Q3	–	Sell	-200,000	Closed	-$2.74M	–	121
2016 Q2	$2.74M	Buy	200,000 +105,500	+112%	+$1.54M	0.71%	44
2016 Q1	$1.81M	Hold	94,500	–	–	0.39%	58
2015 Q4	$3.31M	Sell	94,500 -10,500	-10%	-$677K	0.48%	50
2015 Q3	$9.66M	Sell	105,000 -15,000	-13%	-$1.3M	1.23%	18
2015 Q2	$10.5M	Buy	120,000 +7,545	+7%	+$646K	1.03%	16
2015 Q1	$8.35M	Buy	112,455 +30,500	+37%	+$2.15M	0.87%	22
2014 Q4	$4.59M	Sell	81,955 -20,000	-20%	-$1.05M	0.78%	38
2014 Q3	$4.63M	Sell	101,955 -3,045	-3%	-$127K	0.57%	43
2014 Q2	$4.35M	Buy	105,000 +65,000	+163%	+$3.35M	1.07%	28
2014 Q1	$2.77M	Sell	40,000 -5,000	-11%	-$367K	0.63%	31
2013 Q4	$2.71M	Buy	+45,000	New	+$2.45M	0.76%	33

Other funds holding CLVS

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return